Stock listing
OTC:TCDAQ Tricida Inc Stock
Follow Tricida Inc into a list and get an email when it puts out news.
Delisted OTC:TCDAQ no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- OTC:TCDAQ
- Asset type
- Stock
- Exchange
- OTC
- Currency
- USD
Tricida Inc on 6ix
- Calls
- 7 calls with a replay · 7 with a transcript · latest Aug 8, 2022
- Decks
- 9 decks · latest Nov 17, 2022
Where Tricida Inc is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:TCDA · Delisted | NASDAQ | United States | USD |
| OTC:TCDAQ · This page · Delisted | OTC | United States | USD |
Events
| Call | When | Status |
|---|---|---|
| Tricida (TCDA) Q2 2022 Earnings Call | Mon, Aug 08, 2022 · 4:30 PM ET | Replay |
| Tricida (TCDA) Q1 2022 Earnings Call | Tue, May 10, 2022 · 4:30 PM ET | Replay |
| Tricida (TCDA) Q4 2021 Earnings Call | Tue, Mar 29, 2022 · 4:30 PM ET | Replay |
| Tricida (TCDA) Q3 2021 Earnings Call | Mon, Nov 08, 2021 · 4:30 PM ET | Replay |
| Tricida (TCDA) Q2 2021 Earnings Call | Mon, Aug 09, 2021 · 4:30 PM ET | Replay |
| Tricida (TCDA) Q1 2021 Earnings Call | Thu, May 06, 2021 · 4:30 PM ET | Replay |
| Tricida (TCDA) Q4 2020 Earnings Call | Thu, Feb 25, 2021 · 4:30 PM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Corporate Update (November 2022) | Corporate update | 42 slides | Nov 17, 2022 |
| Investor Presentation (January 2022) | Investor deck | 33 slides | Jan 10, 2022 |
| Investor Presentation (March 2021) | Investor deck | 35 slides | Mar 2, 2021 |
| Investor Presentation (January 2021) | Investor deck | 35 slides | Jan 11, 2021 |
| Corporate Update (December 2020) | Corporate update | 16 slides | Dec 8, 2020 |
| Corporate Update (October 2020) | Corporate update | 19 slides | Oct 29, 2020 |
| Investor Presentation (April 2020) | Investor deck | 47 slides | Apr 15, 2020 |
| Investor Presentation (January 2020) | Investor deck | 37 slides | Jan 13, 2020 |
| Investor Presentation (January 2019) | Investor deck | 33 slides | Jan 7, 2019 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Edward J Hejlek Other companies: Enovix Corporation (See Remarks · Jul 14, 2021 – Nov 6, 2022 · Past) | EVP, General Counsel & Secy. · Jun 27, 2018 – Mar 2, 2020 · Past |
| Jeroen B Van Beek Other companies: Kalaris Therapeutics, Inc. (Chief Commercial Officer · Jul 29, 2020 – Nov 16, 2022 · Past) | Chief Comm Officer and Sr VP · Jun 27, 2018 – Jul 2, 2018 · Past |
| Klaus R Dr Veitinger Other companies: Scpharmaceuticals Inc (Director · Since at least Jun 14, 2022) | Director · Jun 15, 2022 – Jun 15, 2022 · Past |
| Marc Cobo Other companies: BridgeBio Oncology Therapeutics, Inc. (Vice President of Finance and Controller · Since at least Apr 21, 2026) | SVP, Finance & CAO · Jun 29, 2020 – Sep 10, 2020 · Past |
| Dawn Parsell Otto | EVP, Clinical Development · Aug 1, 2018 – Feb 28, 2022 · Past |
| Gerrit Klaerner | President and CEO, Director · Jun 27, 2018 – Feb 28, 2022 · Past |
| Jerry M Buysse | Chief Scientific Offr & Sr VP · Jun 27, 2018 – Jun 27, 2018 · Past |
| Robert McKague | EVP, General Counsel · Mar 9, 2020 – Feb 28, 2022 · Past |
| Susannah Cantrell | EVP, Chief Comm. Officer · Jan 28, 2019 – Sep 10, 2020 · Past |
Log in to ask 6ix AI your own questions about Tricida Inc.